{
    "organizations": [],
    "uuid": "3981bd2f9713d60b5be29cebcf9b72f3ff72e834",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-glg-pharma-gets-permission-for-sta/brief-glg-pharma-gets-permission-for-starting-preclinical-trial-in-tnbc-project-idUSFWN1PV13J",
    "ord_in_thread": 0,
    "title": "BRIEF-GLG Pharma Gets Permission For Starting Preclinical Trial In TNBC Project",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Feb 5 (Reuters) - GLG PHARMA SA:\n* GETS PERMISSION FOR STARTING PRECLINICAL TRIAL IN PROJECT TNBC\n* PROJECT TNBC CONCERNS DEVELOPMENT OF THERAPY AGAINST TRIPLE NEGATIVE BREAST CANCER Source text for Eikon: Further company coverage: (Gdynia Newsroom)\n ",
    "published": "2018-02-05T22:38:00.000+02:00",
    "crawled": "2018-02-07T00:03:20.000+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "feb",
        "reuters",
        "glg",
        "pharma",
        "sa",
        "get",
        "permission",
        "starting",
        "preclinical",
        "trial",
        "project",
        "tnbc",
        "project",
        "tnbc",
        "concern",
        "development",
        "therapy",
        "triple",
        "negative",
        "breast",
        "cancer",
        "source",
        "text",
        "eikon",
        "company",
        "coverage",
        "gdynia",
        "newsroom"
    ]
}